Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
6,166,054
-
Share change
-
-322,454
-
Total reported value
-
$721,765,315
-
Price per share
-
$116.62
-
Number of holders
-
135
-
Value change
-
-$34,043,357
-
Number of buys
-
66
-
Number of sells
-
64
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q1 2017
As of 31 Mar 2017,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,166,054 shares.
The largest 10 holders included
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, SCHRODER INVESTMENT MANAGEMENT GROUP, BlackRock Inc., FMR LLC, RENAISSANCE TECHNOLOGIES LLC, NORGES BANK, APG Asset Management N.V., STATE STREET CORP, FORT, L.P., and Carmignac Gestion.
This page lists
136
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.